Public Notification: Asihuri Plus Forte contains hidden drug ingredients
[5-4-2015] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Asihuri Plus Forte, a product promoted for joint and nerve pain. This product was identified by FDA during an examination of international mail shipments.
- Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Consumers are advised that corticosteroid use can impair a person’s ability to fight infections, cause high blood sugar levels, muscle injuries and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland and cause withdrawal symptoms with abrupt discontinuation.
- Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) that was discontinued for human use in the United States due to the risk of serious and life-threatening injuries. The most serious and life-threatening injury associated with phenylbutazone treatment is bone marrow toxicity, which occurs when the body does not produce enough red blood cells, white blood cells, and/or platelets. Certain types of bone marrow toxicity are reversible; however, in rare circumstances it can lead to death. Patients with anemia, low white or red blood cell count, or decreased blood platelets may be at a greater risk of death or serious injury.
- Complete and submit the report online MedWatch Online Voluntary Reporting Form, or:
- Download and complete the form, then submit it via fax at 1-800-FDA-0178.